Evaluation of the effect of enhanced immunization in adults: A cross-sectional study in the southeast city of China

References

• Pattyn J, Hendrickx G, Vorsters A, Van Damme P. Hepatitis B vaccines. J Infect Dis. 2021;224(12 Suppl 2):1–5. doi:10.1093/infdis/jiaa668.
   PubMedGoogle Scholar
• Jing W, Liu J, Liu M. Eliminating mother-to-child transmission of HBV: progress and challenges in China. Front Med. 2020;14(1):21–29. doi:10.1007/s11684-020-0744-2.
   PubMed Web of Science ®Google Scholar
• Wan Y, Fan C, Liu Y, Xu J, Zhao T, Qiu J, et al. Coverage and influencing factors of hepatitis B vaccination among adults in Heilongjiang and Gansu provinces. Chin J Vaccines Immunization. 2020;26(2):207–212.
   Google Scholar
• Xu Y, Wu Q, Xu S, Xu J, Huang Y. Analysis on hepatitis B vaccination and its influencing factors among adults in Zhejiang Province. Chin J Health Educ. 2020;36(3):259–61+284.
   Google Scholar
• World Health Organization. Hepatitis B [OL]. 2019 July 18 [accessed 2022 Apr 5]. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
   Google Scholar
• Cox AL, El-Sayed MH, Kao JH, Lazarus JV, Lemoine M, Lok AS, Zoulim F. Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol. 2020;17(9):533–542. doi:10.1038/s41575-020-0332-6.
   PubMed Web of Science ®Google Scholar
• Block TM, Chang KM, Guo JT. Prospects for the Global Elimination of Hepatitis B. Annu Rev Virol. 2021;8(1):437–458. doi:10.1146/annurev-virology-091919-062728.
   PubMedGoogle Scholar
• Pinto CS, Costa GB, Allaman IB, Gadelha SR. Clinical, epidemiological aspects, and trends of Hepatitis B in Brazil from 2007 to 2018. Sci Rep. 2021;11(1):13986. doi:10.1038/s41598-021-93434-y.
   PubMed Web of Science ®Google Scholar
• Wang H, Men P, Xiao Y, Gao P, Lv M, Yuan Q, Chen W, Bai S, Wu J. Hepatitis B infection in the general population of China: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):811. doi:10.1186/s12879-019-4428-y.
   PubMed Web of Science ®Google Scholar
• Ren W, Ren J, Wu Z, Shen L, Shan H, Dai X, Li J, Liu Y, Qiu Y, Yao J, et al. Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results. Hum Vaccin Immunother. 2020;16(3):687–692. doi:10.1080/21645515.2019.1666612.
   PubMed Web of Science ®Google Scholar
• Yu Z, Deng M, Peng C, Song X, Chen Y, Zhang X, Liu Q, Li Y, Jiang H, Xu X, et al. A system dynamics modelling simulation based on a cohort of hepatitis B epidemic research in east China community. Epidemiol Infect. 2019;147:e86. doi:10.1017/S0950268819000220.
   PubMed Web of Science ®Google Scholar
• Liang X, Cui F. Technical guide for adult Hepatitis B immunization in China. Chin J Gastroenterol Hepatol. 2012;21:197–201.
   Google Scholar
• Steffen G, Sperle I, Harder T, Sarma N, Beermann S, Thamm R, Bremer V, Zimmermann R, Dudareva S. Hepatitis B vaccination coverage in Germany: systematic review. BMC Infect Dis. 2021;21(1):817. doi:10.1186/s12879-021-06400-4.
   PubMed Web of Science ®Google Scholar
• Poethko-Müller C, Zimmermann R, Hamouda O, Faber M, Stark K, Ross RS, Thamm M. Epidemiology of hepatitis A, B, and C among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(5–6):707–715. doi:10.1007/s00103-013-1673-x.
   PubMed Web of Science ®Google Scholar
• Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53(1):68–75. doi:10.1093/cid/cir270.
   PubMed Web of Science ®Google Scholar
• Pileggi C, Papadopoli R, Bianco A, Pavia M. Hepatitis B vaccine and the need for a booster dose after primary vaccination. Vaccine. 2017;35(46):6302–6307. doi:10.1016/j.vaccine.2017.09.076.
   PubMed Web of Science ®Google Scholar
• Bianchi FP, Gallone MS, Gallone MF, Larocca AMV, Vimercati L, Quarto M, Tafuri S. HBV seroprevalence after 25 years of universal mass vaccination and management of non-responders to the anti-Hepatitis B vaccine: an Italian study among medical students. J Viral Hepat. 2019;26(1):136–144. doi:10.1111/jvh.13001.
   PubMed Web of Science ®Google Scholar
• Xie M, Quan H, Zeng Y, Yuan S, Liu Y, Yang Y. Sero-epidemiology study of hepatitis B virus surface antibodies from 2017 to 2019 among Chinese young adults in Hunan Province: a three-year retrospective study. Medicine (Baltimore). 2021;100(29):e26665. doi:10.1097/MD.0000000000026665.
   PubMed Web of Science ®Google Scholar
• Wang S, Tao Y, Tao Y, Jiang J, Yan L, Wang C, Ding Y, Yu J, Zhao D, Chi X, et al. Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional study. BMC Public Health. 2018;18(1):1088. doi:10.1186/s12889-018-5984-6.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yan B, Lu J, Liu J, Kong Q, Wu W, et al. Persistence of immune memory and its related factors at 12 years after hepatitis B vaccination among adults. Chin J Prev Med. 2019;05:497–502.
   Google Scholar
• U.S. Department of Health and Human Services. Hepatitis B basic information. Updated 2020 Aug 31 [ accessed 2020 Nov 18]. https://www.hhs.gov/hepatitis/learnabout-viral-hepatitis/hepatitis-b-basics/index.html.
   Google Scholar
• U.S. Preventive Services Task Force. Screening for Hepatitis B virus infection in adolescents and adults: recommendation statement. Am Fam Physician. 2021;103(8):495–501.
   PubMed Web of Science ®Google Scholar
• Abara WE, Qaseem A, Schillie S, McMahon BJ, Harris AM, Abraham GM, et al. Hepatitis B vaccination, screening, and linkage to care: best practice advice from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2017;167(11):794–804. doi:10.7326/M17-1106.
   PubMed Web of Science ®Google Scholar
• Prabhu M, Susich MK, Packer CH, Hersch AR, Riley LE, Caughey AB. Universal hepatitis B antibody screening and vaccination in pregnancy: a cost-effectiveness analysis. Obstet Gynecol. 2022;139(3):357–367. doi:10.1097/AOG.0000000000004652.
   PubMed Web of Science ®Google Scholar
• Toy M, Hutton D, Harris AM, Nelson N, Salomon JA, So S. Cost-effectiveness of 1-time universal screening for chronic Hepatitis B infection in adults in the United States. Clin Infect Dis. 2022;74(2):210–217. doi:10.1093/cid/ciab405.
   PubMed Web of Science ®Google Scholar
• Su S, Wong WC, Zou Z, Cheng DD, Ong JJ, Chan P, Ji F, Yuen M-F, Zhuang G, Seto W-K, et al. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation. Lancet Glob Health. 2022;10(2):e278–278e287. doi: 10.1016/S2214-109X(21)00517-9.
   PubMed Web of Science ®Google Scholar